Abstract
Is known that the progression of several diseases is dependent on angiogenesis. Nowadays, new therapeutic approaches for use in angiogenesis-dependent diseases difficult to treat and high mortality, like cancer, is stimulating a worldwide search for new natural and synthetic compounds, preferably low cost, for use alone or adjuvant treatment. Thus, the characterization of inhibitors of an…